NYU Langone Health ( Site 1052) — New York, New York

NYU Langone Health ( Site 1052) is a clinical research site located in New York, New York, United States 10016-9196.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

NYU Langone Health ( Site 1052) has participated in 1 clinical trials.

Therapeutic areas: Pulmonary Arterial Hypertension.

Sponsors: Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for NYU Langone Health ( Site 1052)?

NYU Langone Health ( Site 1052) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has NYU Langone Health ( Site 1052) conducted?

NYU Langone Health ( Site 1052) has 1 clinical trials on record. Their work covers Pulmonary Arterial Hypertension.

Is NYU Langone Health ( Site 1052) accredited by Crixeo Health?

NYU Langone Health ( Site 1052) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about NYU Langone Health ( Site 1052)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.